A0A8C2MW48 (A0A8C2MW48_CRIGR) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)
Mitogen-activated protein kinase 14 UniProtKBInterProInteractive Modelling
360 aa; Sequence (Fasta) ;
3 identical sequences: Peromyscus maniculatus bairdii: A0A6I9LHS5; Mus musculus: P47811; Mus caroli: A0A6P5RF57
It is possible new templates exist for this target since these models were created.
Available Structures
121 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound… |
Heteromer P47811; Q8CF89; | 100 | 1×SB4; 2×SO4; 1×EDO; | |||
| Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) |
Heteromer P47811; Q8CF89; | 100 | 1×SB4; 1×TLA; 3×EDO; | |||
| Structure of MAP kinase in complex with a docking peptide |
Heteromer P47811; Q15750; | 100.0 | ||||
| CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A |
Heteromer P47811; Q02078; | 100.0 | ||||
| CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B |
Heteromer O09110; P47811; | 100.0 | ||||
| Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) |
Heteromer P47811; Q8CF89; | 100 | 1×SB4; | |||
| Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide. |
Heteromer P47811; Q15750; | 99.7 | 1×SB4; | |||
| Crystal structure of phosphorylated p38aMAPK in complex with TAB1 |
Heteromer P47811; Q15750; | 100.0 | 1×NI; 1×AGS; 2×MG; | |||
| Structure of p38alpha complex |
Heteromer P47811; P49137; | 100.0 | ||||
| Crystal structure of p38alpha in complex with a MAPK docking partner |
Heteromer P47811; Q9Y6W6; | 100.0 | ||||
| Ternary complex of P38 and MK2 with a P38 inhibitor |
Heteromer P47811; P49137; | 100.0 | 1×39G; | |||
| Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, … | homo-2-mer | 99.71 | 2×87B; 1×ATP; | |||
| Crystal structure of p38 in complex with SR72 | monomer | 100.0 | 7×EDO; 1×O8Q; | |||
| A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing … | monomer | 100.0 | 2×BOG; 1×WHQ; | |||
| Fragment KCL802 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 3×CA; 2×DMS; 2×LOT; | |||
| Fragment KCL_916 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×OFZ; 1×SB4; 4×CA; 1×CL; 1×SO4; | |||
| Fragment KCL_914 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×OG2; 1×SB4; 4×CA; 1×CL; 1×SO4; | |||
| Fragment KCL_804 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 4×CA; 1×308; | |||
| Fragment KCL_771 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 4×CA; 1×CL; 1×OFQ; | |||
| Fragment KCL_1410 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×OG8; 1×SB4; 4×CA; 1×CL; 1×SO4; | |||
| Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 4×CA; 1×LOT; 1×LOW; 1×SO4; | |||
| Fragment KCL_K767 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 3×CA; 1×OL8; | |||
| Fragment KCL_K777 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 3×CA; 1×OKZ; | |||
| Novel p38-alpha crystal lattice with highly exposed p38/TAB1 non-canonical PPI surface. | monomer | 99.71 | 1×SB4; 5×CA; 2×CL; | |||
| Fragment KCL615 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 3×CA; 2×CL; 3×LOW; | |||
| Fragment KCL_1337 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 4×CA; 1×CL; 1×OFW; | |||
| Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 4×CA; 1×CL; 1×OFQ; 2×LOT; | |||
| Fragment KCL_1088 in complex with MAP kinase p38-alpha | monomer | 99.71 | 1×SB4; 6×CA; 2×CL; 1×DMS; 1×EDO; 1×OG5; | |||
| Crystal structure of phosphorylated p38alpha MAP kinase | monomer | 100 | ||||
| Crystal structure of p38 in complex with SR68 | monomer | 100.0 | 1×O8Z; 8×EDO; | |||
| Crystal structure of p38 in complex with SR65 | monomer | 100.0 | 1×O98; 4×EDO; | |||
| Crystal structure of p38 in complex with SR69 | monomer | 100.0 | 1×O8T; 5×EDO; | |||
| Crystal structure of p38 in complex with SR43 | monomer | 100.0 | 1×OU2; 8×EDO; | |||
| Crystal structure of p38 in complex with SR63. | monomer | 100.0 | 1×O8W; 7×EDO; | |||
| Crystal structure of p38 alpha MAPK14 in complex with VPC00628 | monomer | 100 | 1×6SH; | |||
| Mutated Mus Musculus P38 Kinase (mP38) | monomer | 100.0 | 1×PGJ; | |||
| p38a bound with MCP-81 | monomer | 100.0 | 1×OE5; | |||
| Dual binding mode of pyridinylimidazole to MAP kinase p38 | monomer | 99.39 | 1×SB2; | |||
| Crystal structure of WT p38alpha | monomer | 100.0 | 3×MG; 1×SB2; | |||
| Crystal structure of p38alpha C162S in complex with SB20358 and CAS 2094667-81-7 (behind catalytic … | monomer | 99.71 | 1×IIM; 1×87B; | |||
| The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solution | monomer | 99.7 | ||||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP … | monomer | 100.0 | 1×SOV; 4×CL; 1×MG; 1×SO4; 1×DMS; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14274a in complex with MAP… | monomer | 100.0 | 1×SRJ; 5×CL; 1×MG; 1×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL077 in complex with MAP … | monomer | 100.0 | 1×SOJ; 4×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14246a in complex with MAP… | monomer | 100.0 | 1×SR4; 6×CL; 4×SO4; 1×DMS; 1×MG; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP… | monomer | 100.0 | 1×LXS; 6×CL; 1×MG; 1×SO4; 1×DMS; | |||
| Fragment N13788a in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×LOK; 5×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL093 in complex with MAP … | monomer | 100.0 | 1×SQ4; 7×CL; 1×MG; 2×SO4; 1×EDO; | |||
| Fragment N13460a in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×JGG; 5×CL; 1×MG; 1×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP… | monomer | 100.0 | 1×SNJ; 3×CL; 1×MG; 1×SO4; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP … | monomer | 100.0 | 1×SO7; 5×CL; 1×MG; 1×SO4; 1×DMS; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08078b in complex with MAP… | monomer | 100.0 | 1×SMV; 6×CL; 1×MG; 4×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP… | monomer | 100.0 | 1×JFS; 6×CL; 1×MG; 3×SO4; | |||
| Crystal structure of p38alpha in complex with SR154 | monomer | 100.0 | 1×OSZ; 1×EDO; | |||
| Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR276 | monomer | 100.0 | 2×EDO; 1×TKB; | |||
| p38a bound with SR92 | monomer | 100.0 | 1×OEB; 1×EDO; | |||
| Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR159 | monomer | 100.0 | 1×TK5; | |||
| THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTION | monomer | 100.0 | ||||
| Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1 | monomer | 99.7 | ||||
| Crystal structure of WT p38alpha | monomer | 100.0 | 1×SB2; 2×MG; | |||
| MAPK14 bound with SR302 | monomer | 100.0 | 1×TBK; | |||
| MAPK14 bound with SR300 | monomer | 100.0 | 1×TJZ; 2×EDO; 1×MES; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13662a in complex with MAP… | monomer | 100 | 1×RUY; 4×CL; 5×SO4; 1×MG; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13596a in complex with MAP… | monomer | 100 | 1×SSY; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09139b in complex with MAP… | monomer | 100.0 | 1×SLV; 4×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05703b in complex with MAP… | monomer | 100.0 | 1×SLS; 4×CL; 3×SO4; 2×DMS; 1×MG; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ658 in complex with MAP … | monomer | 100.0 | 1×SQV; 5×CL; 1×MG; 2×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment K00283c in complex with MAP… | monomer | 100 | 1×JND; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| Fragment N13565a in complex with MAP kinase p38-alpha | monomer | 100.0 | 4×CL; 1×SO4; 2×LPZ; | |||
| Fragment RZ132 in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×LO8; 6×CL; 1×MG; 2×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13838a in complex with MAP… | monomer | 100 | 1×SQM; 7×CL; 1×MG; 2×SO4; 1×GOL; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11302a in complex with MAP… | monomer | 100 | 1×SVJ; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| Fragment N11290a in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×LOQ; 5×CL; 1×MG; 2×SO4; 2×EDO; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N09036b in complex with MAP… | monomer | 100 | 1×SV4; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP… | monomer | 100.0 | 1×SU7; 5×CL; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N10836b in complex with MAP… | monomer | 100.0 | 1×SVD; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11337a in complex with MAP… | monomer | 100 | 1×SVG; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N06122b in complex with MAP… | monomer | 100 | 1×54F; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08141b in complex with MAP… | monomer | 100 | 1×PO6; 5×CL; 1×MG; 3×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP… | monomer | 100.0 | 1×LVD; 4×CL; 1×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N01381c in complex with MAP… | monomer | 100 | 1×SN4; 6×CL; 1×MG; 3×SO4; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13866a in complex with MAP… | monomer | 100.0 | 1×JGM; 6×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13502a in complex with MAP… | monomer | 100 | 1×AYS; 5×CL; 1×MG; 2×SO4; 1×DMS; | |||
| Fragment N13569a in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×LO5; 7×CL; 1×MG; 2×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13475a in complex with MAP… | monomer | 100.0 | 1×JMM; 5×CL; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08051b in complex with MAP… | monomer | 100 | 1×SWD; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14109a in complex with MAP… | monomer | 100 | 1×SQG; 5×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment S00888c in complex with MAP… | monomer | 100.0 | 1×N9J; 5×CL; 1×MG; 3×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13470a in complex with MAP… | monomer | 100 | 1×A9B; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13430a in complex with MAP… | monomer | 100 | 1×SFY; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13611a in complex with MAP… | monomer | 100.0 | 1×NZ4; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11396a in complex with MAP… | monomer | 100 | 1×SLY; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment PC587 in complex with MAP k… | monomer | 100 | 1×RGY; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL057 in complex with MAP … | monomer | 100.0 | 1×SNV; 4×CL; 1×MG; 1×SO4; 1×DMS; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14074a in complex with MAP… | monomer | 100.0 | 1×7ZC; 6×CL; 1×MG; 1×SO4; 1×ACT; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13413a in complex with MAP… | monomer | 100 | 1×K3D; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP … | monomer | 100.0 | 1×SQ7; 5×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13693a in complex with MAP… | monomer | 100.0 | 1×S7S; 6×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N05711b in complex with MAP… | monomer | 100.0 | 1×2O6; 5×CL; 1×MG; 2×SO4; 1×DMS; | |||
| Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717 | monomer | 100.0 | 1×SO4; 1×LIE; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP… | monomer | 100.0 | 1×6T5; 4×CL; 1×MG; 3×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13418a in complex with MAP… | monomer | 100.0 | 2×A7K; 6×CL; 1×MG; 2×SO4; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment TCJ795 in complex with MAP … | monomer | 100.0 | 1×SQY; 6×CL; 2×SO4; 1×DMS; 1×EDO; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11338a in complex with MAP… | monomer | 100 | 1×SVM; 5×CL; 1×SO4; 1×DMS; | |||
| Fragment N14056a in complex with MAP kinase p38-alpha | monomer | 100.0 | 1×LOE; 7×CL; 1×MG; 2×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP… | monomer | 100 | 1×STV; 5×CL; 1×MG; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP… | monomer | 100.0 | 1×SU7; 5×CL; 1×MG; 1×SO4; 1×DMS; 1×EDO; | |||
| Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579 | monomer | 100.0 | 1×LID; | |||
| p38 inhibitor-bound | monomer | 100.0 | 1×P7B; 1×BOG; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP… | monomer | 100.0 | 1×JFS; 5×CL; 1×SO4; 1×DMS; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11351a in complex with MAP… | monomer | 100 | 1×SW7; 4×CL; 1×MG; 1×SO4; 1×DMS; | |||
| Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone In… | monomer | 99.7 | 1×LI9; | |||
| PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13724a in complex with MAP… | monomer | 100.0 | 1×SQP; 4×CL; 1×MG; 2×SO4; 1×DMS; | |||
| P38 inhibitor-bound | monomer | 100.0 | 1×BOG; 1×P5K; | |||
| Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743 | monomer | 100.0 | 1×LIB; | |||
| P38 inhibitor-bound | monomer | 100.0 | 1×BOG; 1×P79; | |||
| p38 inhibitor-bound | monomer | 100.0 | 1×BOG; 1×P7C; | |||
| P38 inhibitor-bound | monomer | 100.0 | 1×BOG; 1×P78; | |||
| p38 inhibitor-bound | monomer | 100.0 | 1×BOG; 1×P7A; | |||
| Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449 | monomer | 100.0 | 1×LIC; | |||
| Crystal structure of p38 complex with 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(6-morpholin-… | monomer | 99.39 | 1×G2G; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6y4x.1.A | monomer | 0.83 | 1×O8Q; | 100.00 | ||